We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESEA icon
5001
Euroseas
ESEA
$519M
$4K ﹤0.01%
+286
New +$4.61K
FVC icon
5002
First Trust Dorsey Wright Dynamic Focus 5 ETF
FVC
$111M
$4K ﹤0.01%
100
-116
-54% -$4.09K
GBLI icon
5003
Global Indemnity Group
GBLI
$413M
$4K ﹤0.01%
158
+101
+177% +$2.35K
GDDY icon
5004
GoDaddy
GDDY
$12.7B
$4K ﹤0.01%
51
-4,211
-99% -$316K
GDRX icon
5005
GoodRx Holdings
GDRX
$1.27B
$4K ﹤0.01%
796
-39,358
-98% -$194K
GEVO icon
5006
Gevo
GEVO
$401M
$4K ﹤0.01%
2,252
-183,248
-99% -$387K
GOVX icon
5007
GeoVax Labs
GOVX
$3.74M
$4K ﹤0.01%
18
+17
+1,700% +$5.16K
GSIT icon
5008
GSI Technology
GSIT
$260M
$4K ﹤0.01%
2,558
+2,478
+3,098% +$5.16K
HCTI icon
5009
Healthcare Triangle
HCTI
$3.51M
0
HESM icon
5010
Hess Midstream
HESM
$5.11B
$4K ﹤0.01%
135
-1,113
-89% -$31.8K
HITI
5011
High Tide
HITI
$204M
$4K ﹤0.01%
2,586
+2,585
+258,500% +$3.93K
HTGC icon
5012
Hercules Capital
HTGC
$3.17B
$4K ﹤0.01%
310
-8,264
-96% -$112K
HYEM icon
5013
VanEck Emerging Markets High Yield Bond ETF
HYEM
$527M
$4K ﹤0.01%
200
IGHG icon
5014
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
$4K ﹤0.01%
+54
New +$3.78K
IIIV icon
5015
i3 Verticals
IIIV
$325M
$4K ﹤0.01%
181
-2,233
-93% -$50.4K
INFU icon
5016
InfuSystem Holdings
INFU
$249M
$4K ﹤0.01%
455
-100
-18% -$815
INVZ icon
5017
Innoviz Technologies
INVZ
$114M
$4K ﹤0.01%
999
-3,215
-76% -$15.3K
INZY
5018
DELISTED
Inozyme Pharma
INZY
$4K ﹤0.01%
+3,598
New +$6.29K
IPW icon
5019
iPower
IPW
$712K
$4K ﹤0.01%
5
+2
+67% +$2.31K
IPWR icon
5020
Ideal Power
IPWR
$70M
$4K ﹤0.01%
358
+215
+150% +$2.42K
ISSC icon
5021
Innovative Solutions & Support
ISSC
$407M
$4K ﹤0.01%
444
-380
-46% -$3.35K
ITRM
5022
DELISTED
Iterum Therapeutics
ITRM
$4K ﹤0.01%
4,401
+3,079
+233% +$4.38K
IVDA icon
5023
Iveda Solutions
IVDA
$6.09M
$4K ﹤0.01%
985
-4
-0.4% -$21
JOB icon
5024
GEE Group
JOB
$24.9M
$4K ﹤0.01%
8,689
+8,613
+11,333% +$5.78K
JSMD icon
5025
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
$1.1B
$4K ﹤0.01%
83
-1
-1% -$53

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.